Results 251 to 260 of about 4,157,079 (311)

Phase 1 Study of KITE-222, an Autologous CLL-1-Directed CAR T-cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia. [PDF]

Clin Cancer Res
Daver N, Blachly JS, Ghobadi A, Advani A, Muffly L, Garciaz S, Recher C, Kahali B, Sun J, Jung AS, Filosto S, Mao D, Granados E, Sallman DA.   +13 more
europepmc   +1 more source

Sustainable Materials Design With Multi‐Modal Artificial Intelligence

Advanced Science, EarlyView.
Critical mineral scarcity, high embodied carbon, and persistent pollution from materials processing intensify the need for sustainable materials design. This review frames the problem as multi‐objective optimization under heterogeneous, high‐dimensional evidence and highlights multi‐modal AI as an enabling pathway.
Tianyi Xu, Tianshuo Wei, Yan Ge, Bo Peng, Yue Li, Maolin Wang, Peng Wen, Chao Yang, Ye Wei   +8 more
wiley   +1 more source

CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results. [PDF]

J Immunother Cancer
Silbert SK, Gava F, Yates B, Rankin AW, Rocco JM, Shao L, Dreyzin A, Cai Y, Lamplugh C, Han KL, Prochazkova M, Little L, Foley T, Sankaran H, Martin K, Garces P, Jin P, Chien CD, Taylor N, Fry TJ, Yuan CM, Wang HW, Stroncek DF, Highfill SL, Shalabi H, Shah NN.   +25 more
europepmc   +1 more source

Ferroelectric Devices for In‐Memory and In‐Sensor Computing

Advanced Science, EarlyView.
Inspired by biological systems, in‐memory and in‐sensor computing overcome von Neumann bottlenecks. Ferroelectric devices can mimic synaptic functions and sense stimuli like light or force, therefore are ideal for these paradigms. This review introduces the ferroelectric devices applied for in‐memory and in‐sensor computing, covering their structures ...
Hong Fang, Ronghuan Xie, Qiang Cao, Shishen Yan, Xiaolin Wang, Limei Zheng   +5 more
wiley   +1 more source

Beyond resistance: optimizing CAR-T sequencing following bispecific antibody failure in DLBCL. [PDF]

J Transl Med
Zhang W, Fang Y, Gao S, Yao Y.
europepmc   +1 more source

Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation. [PDF]

EClinicalMedicine
Orofino G, Sánchez-Ortega I, Mota JS, Aroldi A, Castilla-Llorente C, Bigenwald C, Dalle JH, Yacouben K, Di Blasi R, Galli E, Grandage V, Palasciano A, Bacon L, Franke GN, Fandrei D, Merz M, George L, Lopez-Corral L, Hecker JS, Mannina D, Bramanti S, Martin Gonzalez JA, Martínez-Cibrian N, Petersen SL, Polgarova K, Protheroe R, Richardson D, Ram R, Elias S, von Tresckow B, Stölzel F, Streiss I, Vallet N, Knippenberg J, Tomas AA, Pagliuca S, Malard F, Kuball J, Ruggeri A.   +38 more
europepmc   +1 more source

Chimeric switch scaffold protein augments CAR synapse formation and signaling networks. [PDF]

J Immunother Cancer
Park CI, Kim S, Shim H, Nguyen MH, Cho WK, Kim CH.   +5 more
europepmc   +1 more source

Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapy. [PDF]

J Immunother Cancer
Ferry SL, Abdullah L, Balasubramanian A, Nowak EC, Carl A, Turnquist A, Mohamed A, Usherwood E, Sundrud M, Huang Y.   +9 more
europepmc   +1 more source

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T-Cell Immunotherapy for B-Cell Malignancies: A Case Series. [PDF]

Hematol Oncol
Cavallaro G, Ferrari S, Pollastri A, Di Credico E, Meli C, Rondi M, Putelli A, Lussana F, Grassi A, Rambaldi A, Valetti TM, Riva I, Gritti G.   +12 more
europepmc   +1 more source

Outpatient Rescue With Stem Cells Boost for Refractory Hematotoxicity Following anti-BCMA CAR T-Cell Therapy: A Case Report. [PDF]

Case Rep Hematol
Loukhnati M, Hebraud B, Cazaux M, Borel C, Bories P, Martignoles JA, Granell M, Cougoul P, Dion J, Oberic L, Huynh A, Tazi I, Perrot A.   +12 more
europepmc   +1 more source